itraconazole and Orthomyxoviridae Infections

itraconazole has been researched along with Orthomyxoviridae Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brunotte, L; Goretzko, J; Kühnl, A; Ludwig, S; Rescher, U; Schloer, S	1

Other Studies

1 other study(ies) available for itraconazole and Orthomyxoviridae Infections

Article	Year
The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo. Emerging microbes & infections, 2019, Volume: 8, Issue:1 Topics: A549 Cells; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Repositioning; Human Umbilical Vein Endothelial Cells; Humans; Influenza A virus; Itraconazole; Mice; Mortality; Orthomyxoviridae Infections; Triazoles; Vero Cells; Viral Load; Virus Replication	2019

Article

Year

The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo.

Emerging microbes & infections, 2019, Volume: 8, Issue:1

Topics: A549 Cells; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Repositioning; Human Umbilical Vein Endothelial Cells; Humans; Influenza A virus; Itraconazole; Mice; Mortality; Orthomyxoviridae Infections; Triazoles; Vero Cells; Viral Load; Virus Replication

2019